Door to Intravenous Tissue Plasminogen Activator Time and Hospital Length of Stay in Acute Ischemic Stroke Patients, Georgia, 2007-2013

This study evaluates the benefit of reducing door-to-treatment (DTT) time as measured by hospital length of stay (LOS).

Source: Journal of Stroke and Cerebrovascular Diseases - February 4, 2016 Category: Neurology Authors: Moges Seyoum Ido, Ike S. Okosun, Rana Bayakly, Lydia Clarkson, James Lugtu, Sanita Floyd, Kerrie Krompf, Michael Frankel Source Type: research